UGT2B15 Inhibitors
DBCAT004457Pharmacologic class
A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of September 06, 2018
Which targets do UGT2B15 Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account